Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...

Heartflow (NASDAQ:HTFL), a MedTech firm backed by private equity firms including Bain Capital, climbed ~50% on its first ...

Bain Capital Specialty Finance delivered a strong Q2, reinforcing its value, dividend safety, and limited downside risk. Read ...

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

Pharma is looking for fewer, scaled providers at an enterprise level to reduce risk and provide a better-integrated service,' ...

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable ...

Bain Capital Specialty Finance, Inc. (BCSF) Q2 2025 Management View CEO Michael Alexander Ewald highlighted "Q2 net investment income per share was $0.47, representing an annualized yield on book ...

On a per-share basis, the Boston-based company said it had profit of 37 cents. Earnings, adjusted for investment costs, were ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five ...

Bain Capital and 11North Partners paid $395 million for a portfolio of 10 shopping centers in Florida and South Carolina, ...

A joint venture between Bain Capital and 11North Partners has purchased a portfolio of 10 open-air retail centers in Florida ...